Journal ArticleDOI
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers Within the Treatment System
Reads0
Chats0
TLDR
Nine key barriers that prevent access to evidence-based care, including stigma; inadequate clinical training; a dearth of addiction specialists; lack of integration of MOUD provision in practice; regulatory, statutory, and data sharing restrictions; and financial barriers are included.Abstract:
| Even though evidence-based treatment for opioid use disorders (OUD) is eff ective, almost four in fi ve Americans with OUD do not receive any form of treatment. The gap in access to evidencebased care, including treatment with medications for OUD, stems in part from barriers to change within the health care system. This paper includes nine key barriers that prevent access to evidence-based care, including stigma; inadequate clinical training; a dearth of addiction specialists; lack of integration of MOUD provision in practice; regulatory, statutory, and data sharing restrictions; and fi nancial barriers. Action from a number of actors is urgently needed to address this crisis.read more
Citations
More filters
Assessing the Evidence
TL;DR: It is shown that when students embark on research they first have to learn methodology, and that when they write up that research they should start by explaining their methodology.
Policies Related to Opioid Agonist Therapy for Opioid Use Disorders
Rachel M. Burns,Rosalie Liccardo Pacula,Sebastian Bauhoff,Adam J. Gordon,Hollie Hendrikson,Douglas L. Leslie,Bradley D. Stein +6 more
TL;DR: In this article, the authors surveyed state Medicaid officials and other designated state substance abuse treatment specialists about their state's recent history of Medicaid coverage and policies pertaining to methadone and buprenorphine.
Journal ArticleDOI
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.
Ofer Amram,Ofer Amram,Solmaz Amiri,Victoria Panwala,Robert Lutz,Paul J. Joudrey,Eugenia Socías +6 more
TL;DR: In response to the COVID-19 pandemic, the US Substance Abuse and Mental Health Services Administration (SAMHSA) allowed for an increase in methadone take-home doses for the treatment of...
Journal ArticleDOI
Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel.
Lynn Kohan,Sudheer Potru,Sudheer Potru,Antje M Barreveld,Michael Sprintz,Olabisi Lane,Anuj Aryal,Trent Emerick,Anna Dopp,Sophia Chhay,Eugene R. Viscusi +10 more
TL;DR: In this paper, a multisociety working group on Opioid Use Disorder (OUD) was created to provide recommendations to aid physicians in the management of patients receiving buprenorphine for OUD in the perioperative setting.
Journal ArticleDOI
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review.
TL;DR: In this paper, the authors describe new services and service modifications implemented by treatment and harm reduction programs serving people who use opioids and discuss implications for policy and practice, and identify major themes around key service modifications and innovations implemented across programs serving PWUOs.
References
More filters
Journal ArticleDOI
Implicit bias in healthcare professionals: a systematic review
TL;DR: The evidence indicates that healthcare professionals exhibit the same levels of implicit bias as the wider population, and the need for the healthcare profession to address the role of implicit biases in disparities in healthcare is highlighted.
Journal ArticleDOI
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo,Luis Sordo,Gregorio Barrio,María J. Bravo,B. Iciar Indave,Louisa Degenhardt,Louisa Degenhardt,Lucas Wiessing,Marica Ferri,Roberto Pastor-Barriuso +9 more
TL;DR: Retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids.
Journal ArticleDOI
Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review
TL;DR: It is indicated that negative attitudes of health professionals towards patients with substance use disorders are common and contribute to suboptimal health care for these patients.
Journal ArticleDOI
Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later
TL;DR: SBIRT was feasible to implement and the self-reported patient status at 6 months indicated significant improvements over baseline, for illicit drug use and heavy alcohol use, with functional domains improved, across a range of health care settings and a rangeof patients.
Journal ArticleDOI
The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review
TL;DR: A range of interventions demonstrate promise for achieving meaningful improvements in stigma related to substance use disorders and the limited evidence indicates that self-stigma can be reduced through therapeutic interventions such as group-based acceptance and commitment therapy.